29 April,2021 06:36 PM IST | New Delhi | PTI
Pic/AFP
Bharat Biotech on Thursday announced a cut in price of its COVID-19 vaccine ''Covaxin'' it plans to sell to the states to Rs 400 per dose from the earlier Rs 600.
This follows a widespread criticism of its pricing policy as it sold Covaxin to the central government at Rs 150 per dose.
"Recognising the enormous challenges in the public healthcare system, we have made Covaxin available to state governments at a price of 400/ dose", Bharat Biotech said in its announcement.
The company is deeply concerned with the critical pandemic circumstances that India is facing at this time, it added.
ALSO READ
Mumbai: Delayed adult TB vaccine survey in city likely to begin soon
Israeli strikes in Gaza kill more than a dozen as health workers press on with polio vaccines
Online vaccine management portal U-Win to be launched later this month: Union health secretary
First 100,000 doses of mpox vaccine reach Congo. But it's fraction of what is needed
The first 100,000 doses of mpox vaccine reach Congo. But it's a fraction of what is needed
Serum Institute of India (SII) had on Wednesday slashed the price of its COVID-19 vaccine ''Covishield'' to Rs 300 per dose from the earlier Rs 400 for state governments.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
